Unknown PHASE4 INTERVENTIONAL 2-arm NCT04963257

Sertraline Combined With Fluvoxamine in the Treatment of Refractory Obsessive-compulsive Disorder

A Randomized Controlled Trial of Sertraline Combined With Fluvoxamine in the Treatment of Refractory Obsessive-compulsive Disorder

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University

Conditions OCD

Interventions sertraline sertraline fluvoxamine

Updated 4 times since 2021 Last updated: Jul 6, 2021 Started: Jan 1, 2020 Primary completion: Dec 31, 2023 Completion: Dec 31, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates OCD and is currently ongoing. Second Affiliated Hospital, School of Medicine, Zhejiang University leads this study, which shows 4 recorded versions since 2020 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

4 versions recorded

Feb 2025 — Present [monthly]

Unknown PHASE4

Status: Recruiting → Unknown
Sep 2024 — Feb 2025 [monthly]

Recruiting PHASE4
Jul 2024 — Sep 2024 [monthly]

Recruiting PHASE4
Sep 2021 — Jul 2024 [monthly]

Recruiting PHASE4

First recorded

Jan 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Second Affiliated Hospital, School of Medicine, Zhejiang University

Data source: Second Affiliated Hospital, School of Medicine, Zhejiang University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Yiwu, China